ResoTher Pharma
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Study of RTP-026 to Assess Safety, Tolerability and Efficacy in Patients With ST-Elevation Myocardial Infarction (STEMI) (NCT06465303) | ResoTher Pharma | 2024-07-16 |
Track ResoTher Pharma automatically
Every clearance here is in the API, with alerts when new ones post.